COMMONWEALTH MEDICAL ASSOCIATION

Company limited by guarantee

Company Registration Number:
02812942 (England and Wales)

Unaudited micro entity accounts for the year ended 31 December 2024

Period of accounts

Start date: 01 January 2024

End date: 31 December 2024

COMMONWEALTH MEDICAL ASSOCIATION

Company limited by guarantee

Contents of the Financial Statements

for the Period Ended 31 December 2024

Company Information - 3
Report of the Directors - 4
Income and Expenditure Account - 5
Balance sheet - 6
Footnotes to the Balance Sheet - 8

COMMONWEALTH MEDICAL ASSOCIATION

Company limited by guarantee

Company Information

for the Period Ended 31 December 2024




Director: Dr Colin Anthony Abel
Dr Mary Amoakoh-Coleman
Dr Rajakani Vivekanandan Asokan
Dr Vishi Yohan Beharry
Dr Gordon Caruana-Dingli
Prof Dr Jhonrose A Jayalal
Dr Joy Mugambi
Dr Vasu Pillai
Dr Muruga Raj Rajathurai
Dr Kaumba Manyoni Tolupo
Registered office: British Medical Association Building
Tavistock Square
London
WC1H 9JP
Company Registration Number: 02812942 (England and Wales)

COMMONWEALTH MEDICAL ASSOCIATION

Company limited by guarantee

Directors' Report Period Ended 31 December 2024

The directors present their report with the financial statements of the company for the period ended 31 December 2024

Principal Activities

To assist and strengthen the capacities of national medical associations of countries within the Commomwealth to improve the health and wellbeing of their communities.

Directors

The directors shown below have held office during the whole of the period from 01 January 2024 to 31 December 2024
Dr Colin Anthony Abel
Dr Mary Amoakoh-Coleman
Prof Dr Jhonrose A Jayalal
Dr Joy Mugambi
Dr Muruga Raj Rajathurai

The director(s) shown below were appointed to the company during the period
Dr Rajakani Vivekanandan Asokan
01 January 2024
Dr Vishi Yohan Beharry
01 January 2024
Dr Gordon Caruana-Dingli
01 January 2024
Dr Vasu Pillai
01 January 2024
Dr Kaumba Manyoni Tolupo
01 January 2024

This report was approved by the board of directors on 18 July 2025
And Signed On Behalf Of The Board By:

Name: Dr Colin Anthony Abel
Status: Director

Name: Prof Dr Jhonrose A Jayalal
Status: Director

Name: Dr Joy Mugambi
Status: Director

COMMONWEALTH MEDICAL ASSOCIATION

Company limited by guarantee

Income and Expenditure Account

for the Period Ended 31 December 2024


2024
£

2023
£
Turnover 6,622 3,771
Cost of Materials ( 2,451 ) ( 4,556 )
Other charges ( 798 ) ( 1,939 )
Surplus or (Deficit) for Period 3,373 ( 2,724 )

COMMONWEALTH MEDICAL ASSOCIATION

Company limited by guarantee

Balance sheet

As at 31 December 2024


2024
£

2023
£
Current assets: 9,257 5,884
Net current assets (liabilities): 9,257 5,884
Total assets less current liabilities: 9,257 5,884
Total net assets (liabilities): 9,257 5,884
Reserves: 9,257 5,884

COMMONWEALTH MEDICAL ASSOCIATION

Company limited by guarantee

Balance sheet continued

For the year ending 31 December 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions of the small companies regime applicable to micro-entities.

This report was approved by the board of directors on 18 July 2025
And Signed On Behalf Of The Board By:

Name: Dr Colin Anthony Abel
Status: Director

Name: Prof Dr Jhonrose A Jayalal
Status: Director

Name: Dr Joy Mugambi
Status: Director

The notes form part of these financial statements

COMMONWEALTH MEDICAL ASSOCIATION

Company limited by guarantee

Footnotes to the Financial Statements

for the Period Ended 31 December 2024

  • 1. Employee Information

    Average number of employees: 0

COMMONWEALTH MEDICAL ASSOCIATION

Company limited by guarantee

Footnotes to the Financial Statements

for the Period Ended 31 December 2024

  • 2. Off balance sheet disclosure

    No